Evidence map›Paper›PMID 37398257›Full record

ArticlebioRxiv : the preprint server for biology2023

Small Molecule

Alexander Bogdanov, Mariam N Salib, Alexander B Chase, Heinz Hammerlindl, Mitchell N Muskat, Stephanie Luedtke, Elany Barbosa da Silva, Anthony J O'Donoghue, Lani F Wu, Steven J Altschuler and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Alexander BogdanovScripps Institution of Oceanography, University of California, San Diego, La Jolla, CA 92093, USA.
Mariam N SalibDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.
Alexander B ChaseScripps Institution of Oceanography, University of California, San Diego, La Jolla, CA 92093, USA.
Heinz HammerlindlDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Mitchell N MuskatScripps Institution of Oceanography, University of California, San Diego, La Jolla, CA 92093, USA.
Stephanie LuedtkeSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093.
Elany Barbosa da SilvaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093.
Anthony J O'DonoghueSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093.
Lani F WuDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Steven J AltschulerDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Tadeusz F MolinskiDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.
Paul R JensenScripps Institution of Oceanography, University of California, San Diego, La Jolla, CA 92093, USA.
University of California San Diego · USScripps Institution of Oceanography · USUniversity of California, San Francisco · US

Funding

Natural Product Genome MiningR01GM085770 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENSEN, PAUL R, MOORE, BRADLEY S · 2009 to 2024
$5.8M
Changing Paradigms in Natural Product Discovery: A Molecule to Microbe ApproachR21AT010493 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENSEN, PAUL R · 2019 to 2020
$433k
NCCIH NIH HHS R21 AT010493NIGMS NIH HHS R01 GM085770
6 · The paper itself

Abstract

Microbial natural products remain an important resource for drug discovery. Yet, commonly employed discovery techniques are plagued by the rediscovery of known compounds, the relatively few microbes that can be cultured, and laboratory growth conditions that do not elicit biosynthetic gene expression among myriad other challenges. Here we introduce a culture independent approach to natural product discovery that we call the Small Molecule In situ Resin Capture (SMIRC) technique. SMIRC exploits in situ environmental conditions to elicit compound production and represents a new approach to access poorly explored chemical space by capturing natural products directly from the environments in which they are produced. In contrast to traditional methods, this compound-first approach can capture structurally complex small molecules across all domains of life in a single deployment while relying on Nature to provide the complex and poorly understood environmental cues needed to elicit biosynthetic gene expression. We illustrate the effectiveness of SMIRC in marine habitats with the discovery of numerous new compounds and demonstrate that sufficient compound yields can be obtained for NMR-based structure assignment. Two new compound classes are reported including one novel carbon skeleton that possesses a functional group not previously observed among natural products and a second that possesses potent biological activity. We introduce expanded deployments, in situ cultivation, and metagenomics as methods to facilitate compound discovery, enhance yields, and link compounds to producing organisms. This compound first approach can provide unprecedented access to new natural product chemotypes with broad implications for drug discovery.

Indexed as

Biological sciences – biochemistrydrug discoveryenvironmental metabolomicsmicrobiomesnatural productsPhysical sciences – chemistry

Identifiers

PMID37398257
PMCPMC10312467
OpenAlexW4323306943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.